Hjem › Burkitts lymfom › New Jersey
Burkitts lymfom kliniske forsøg i New Jersey
8 studier for Burkitts lymfom søger deltagere på steder i New Jersey.
Byer i New Jersey
Officiel studietekst (engelsk)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Hackensack University Medical Center, Hackensack
- Morristown Medical Center, Morristown
- Jersey Shore Medical Center, Neptune City
- og 2 flere
RekruttererFase 2
366 Days – 46 Years · Alle køn · Opdateret 2. okt. 2026 · NCT06124157Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Hackensack University Medical Center, Hackensack
- Morristown Medical Center, Morristown
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick
- og 1 flere
RekruttererFase 2
365 Days · Alle køn · Opdateret 25. sep. 2026 · NCT06317662Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Hackensack Meridian Health, Hackensack
- Carol G Simon Cancer Center, Morristown
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07648264Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick
RekruttererFase 1/2
6 Months – 25 Years · Alle køn · Opdateret 17. sep. 2026 · NCT06395103A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Hackensack University Medical Center, Hackensack
- Morristown Medical Center, Morristown
- Saint Peter's University Hospital, New Brunswick
- og 4 flere
RekruttererFase 2
Alder 1 til 30 · Alle køn · Opdateret 1. sep. 2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Hackensack University Medical Center, Hackensack
- Morristown Medical Center, Morristown
- Jersey Shore Medical Center, Neptune City
- og 4 flere
RekruttererFase 3
365 Days – 25 Years · Alle køn · Opdateret 25. aug. 2026 · NCT03959085Study of SGR-1505 in Mature B-Cell Neoplasms
- Regional Cancer Care Associates, Hackensack
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 13. feb. 2026 · NCT05544019The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- Hackensack University Medical Center, Hackensack
RekruttererFase 2
Alder 1 til 25 · Alle køn · Opdateret 4. maj 2025 · NCT03509961Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.